Uptake of anti-retroviral therapy low in young gay men

June 4, 2014 by Fran Strachan
Uptake of anti-retroviral therapy low in young gay men
Credit: Thinkstock

Lack of social welfare support and poor clinical engagement is delaying newly diagnosed, young HIV-positive gay men from accessing the anti-retroviral therapies (ART) that could save their lives.

New research by UNSW's Centre for Social Research in Health, published in HIV Medicine, identifies the potential challenges in promoting the uptake of ART among this group of under 30-year-old men in Australia.

"Younger, recently diagnosed men are likely to feel healthier and be free of HIV symptoms compared to their older HIV-positive peers, making them less inclined to begin treatment and this decision is often supported by their clinician," said lead researcher Dr Limin Mao.

"Young often aren't ready to commit to life-long treatment and its potential side-effects immediately after receiving their HIV diagnosis."

The study was based on responses from 1,911 HIV-positive men who participated in the Gay Community Period Surveys across six states and territories between 2010 and 2012.

Dr Mao said the cost of obtaining ART drugs could also be prohibitive to people with HIV even if they are covered by Medicare and warns that the proposed introduction of GP co-payments will further impact on ART uptake.

"ART is heavily subsidised by the Australian government, but there is still an up-front drug co-payment that's required. This, combined with the travel costs of getting to a clinic regularly for prescriptions is expensive," she said.

"HIV is still a highly stigmatised disease – many newly diagnosed people, particularly those who are employed, find it hard to combine regular visits to clinics and pharmacies with work," said Dr Mao.

"Coping with life-long ART use without disclosing HIV status in the workplace can be very difficult."

Uptake of routine annual STI testing – an indication of good clinical care in HIV management – is also low in gay men not using ART, suggesting they are not accessing quality clinical services.

Dr Mao recommends that more guidance and support should be provided to newly diagnosed young gay men, so they can access better clinical care and social support across the spectrum of issues around living with HIV.

"People shouldn't be simply coerced into initiating a life-long treatment without having the appropriate financial, clinical and social support," said Dr Mao.

Explore further: Focus on undiagnosed HIV

More information: Mao, L., de Wit, J., Kippax, S., Prestage, G. and Holt, M. (2014), "Younger age, recent HIV diagnosis, no welfare support and no annual sexually transmissible infection screening are associated with nonuse of antiretroviral therapy among HIV-positive gay men in Australia." HIV Medicine. DOI: 10.1111/hiv.12169

Related Stories

Focus on undiagnosed HIV

January 20, 2014
A new study that aims to identify rates of undiagnosed HIV in Australia's gay community will offer free testing across six states and territories, including at Sydney's Gay and Lesbian Mardi Gras.

Unprotected sex among young gay men on the rise

October 21, 2013
Unprotected sex with casual partners - one of the key drivers of HIV transmission among gay men - has risen significantly for those aged under 25.

Gay men divided over use of HIV prevention drug

April 6, 2014
A drug hailed as a lifesaver for many people infected by HIV is at the heart of a rancorous debate among gay men, AIDS activists and health professionals over its potential for protecting uninfected men who engage in gay ...

Younger people, men and those without children more likely to drop out of HIV care in South Africa

February 20, 2014
Analysis carried out by an academic at Royal Holloway, University of London has revealed that younger people, men and those without children are more likely to stop attending clinics for HIV treatment in South Africa.

Good news for HIV treatment as prevention

March 7, 2014
The Kirby Institute at UNSW Australia welcomes early results from the PARTNER study, which has found that HIV positive gay men who are on treatment and have undetectable viral load are not transmitting HIV to their partners.

In Africa, STI testing could boost HIV prevention

May 28, 2014
To maximize HIV prevention efforts in South Africa and perhaps the broader region, public health officials should consider testing for other sexually transmitted infections when they test for HIV, according to a new paper ...

Recommended for you

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

Scientists capture first high-resolution image of key HIV protein transitional state

July 13, 2017
A new, three-dimensional snapshot of HIV demonstrates the radical structural transformations that enable the virus to recognize and infect host cells, according to a new study led by scientists at The Scripps Research Institute ...

Barrier to autoimmune disease may open door to HIV, study suggests

July 11, 2017
Researchers from the University of Colorado School of Medicine have discovered that a process that protects the body from autoimmune disease also prevents the immune system from generating antibodies that can neutralize the ...

Team tests best delivery mode for potential HIV vaccine

June 20, 2017
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.